BofA Securities backs these picks for their great quality, c...
BofA Securities backs these picks for their great quality, consistent execution, and profitability, leading to quick compounded earnings, despite GLP-1 drugs sector uncertainties. Novo Nordisk's SELECT trial financial figures will be a key aspect in November.
Boston Sci, Stryker, Dexcom, Shockwave Are BoA's Top Medtech Picks
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment